14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Mar 27, 2019 $1.75 $1.76 $1.60 $1.69 4 763
Mar 26, 2019 $1.56 $1.74 $1.56 $1.73 4 696
Mar 25, 2019 $1.62 $1.63 $1.60 $1.60 1 477
Mar 22, 2019 $1.63 $1.72 $1.58 $1.62 8 228
Mar 21, 2019 $1.70 $1.79 $1.64 $1.67 20 357
Mar 20, 2019 $1.67 $1.79 $1.63 $1.70 3 915
Mar 19, 2019 $1.75 $1.75 $1.62 $1.62 3 761
Mar 18, 2019 $1.69 $1.76 $1.65 $1.76 5 955
Mar 15, 2019 $1.79 $1.79 $1.65 $1.65 8 410
Mar 14, 2019 $1.73 $1.73 $1.65 $1.73 6 066
Mar 13, 2019 $1.73 $1.88 $1.72 $1.74 3 845
Mar 12, 2019 $1.76 $1.88 $1.72 $1.72 19 873
Mar 11, 2019 $1.74 $1.90 $1.74 $1.76 13 808
Mar 08, 2019 $2.08 $2.12 $1.70 $1.74 102 361
Mar 07, 2019 $1.40 $2.16 $1.39 $2.04 128 606
Mar 06, 2019 $1.30 $1.30 $1.25 $1.27 6 184
Mar 05, 2019 $1.30 $1.42 $1.25 $1.25 13 075
Mar 04, 2019 $1.28 $1.31 $1.21 $1.25 2 879
Mar 01, 2019 $1.20 $1.36 $1.20 $1.35 11 073
Feb 28, 2019 $1.28 $1.28 $1.20 $1.21 5 857
Feb 27, 2019 $1.26 $1.30 $1.26 $1.26 8 657
Feb 26, 2019 $1.28 $1.28 $1.21 $1.25 2 948
Feb 25, 2019 $1.30 $1.30 $1.28 $1.29 854
Feb 22, 2019 $1.29 $1.33 $1.27 $1.33 8 510
Feb 21, 2019 $1.33 $1.35 $1.33 $1.35 3 795
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT